[S-31] Symposium 31

[S-31-4] Pathophysiological Imaging of PD and APS -Toward Realization of Disease-Modifying Therapies-

Hitoshi Shimada^1,2,3 (1.Department of Functional Neurology & Neurosurgery, Center for Integrated Human Brain Science, Brain Research Institute, Niigata University, Japan, 2.Department of Functional Brain Imaging, Institute for Quantum Medical Science, Institutes for Quantum and Radiological Science and Technology, Japan, 3.Department of Neurology, Chiba University, Japan)

Dr. Shimada obtained his M.D. from Chiba University in 2003 and trained in Neurology at Chiba University Hospital and affiliated hospitals. He received his Ph.D. degree in Advanced Life Science from Chiba University, Japan, in 2009. He was a postdoctoral researcher from April 2009, a researcher from December 2009, senior researcher from July 2014, and the principal researcher from July 2017 at the Department of Functional Brain Imaging Research, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology (QST), Chiba, Japan. He has transferred to the Center for integrated human brain science of Niigata University as a professor as of April 1st, 2021. His current research interests include Molecular Neuroimaging (especially neuropathological imaging such as amyloid, tau, and synuclein PET imaging) in Neurodegenerative disorders, physiological background of psychiatric symptoms, human perception and cognition, and neuroplasticity.